Danish authorities reported on the 20th (local time) that two medical workers who had been vaccinated with AstraZeneca (AZ) corona19 vaccine had symptoms of blood clots and cerebral hemorrhage, and one of them died.
Authorities say the other of the two is in serious condition.
Danish health officials confirmed that they had received two serious cases reported that day, and said they had received the AZ vaccine within 14 days.
The authorities did not disclose specific information, such as when the two people started getting sick.
Earlier, Denmark announced on the 11th that a 60-year-old woman who received the AZ vaccine in her country died after forming a blood clot, and that it would temporarily suspend its use for two weeks as a preventive measure.
This is the second case of death after AZ vaccination in Denmark, according to the New York Times (NYT).
The European Medicines Agency (EMA), an agency that evaluates medicines and vaccines in the European Union, said on the 18th that blood clots were formed after vaccination with AZ, saying, "The AZ vaccine is safe and the benefit is greater than the risk of side effects." Some of the countries that have withheld AZ vaccination, including Germany, France, and Italy, have resumed vaccination this week.
Danish health officials say they need more time to decide whether or not to use the vaccine, Reuters reported.
The authorities said, "We will prioritize cases suspected of serious side effects and thoroughly investigate whether there is any association with the vaccine."
The pharmaceutical company AstraZeneca reaffirmed its position that the safety of the vaccine is a top priority, without giving an immediate response regarding the case of a blood clot in Denmark that has occurred, and hopes that vaccination can be resumed across Europe after a careful decision by regulatory authorities.